Pre-Market Review
COVID-19 Drug Trials Push Shares Higher

Posted by James Hughes -
Scope Markets

Shares on Wall Street surged during Monday’s session after drug company Moderna reported positive data on early-stage coronavirus vaccine trials. Shares in Europe and Asia followed suit. Futures markets are pointing to a strong open in Europe on Tuesday morning.

Elsewhere, Chinese President Xi Jinping said that his country would provide $2 billion over the next two years to help other countries fight the impact of the pandemic. This came just hours after US President Donald Trump threatened to completely withdraw all funding from the WHO. He said this could happen if they could not show significant improvements and prove it is independent of China.

This comes as Trump continues to get criticism for his handling of the crisis. Yesterday he announced he was taking an anti-malaria drug to stop him contracting COVID-19. It is entirely unproven to have any effect at all. Trump remains under pressure with his handling of the pandemic the biggest threat to his re-election campaign. His plan over recent months to combat that is to focus on China.

UK unemployment afloat

Early on Tuesday, UK unemployment data was out for March. It showed that the overall unemployment rate did not increase as much as had been expected. The rate came in at 3.9%, which is lower than the 4.4% that had been expected. However, it must be stressed that these numbers are for March. The UK only saw lockdown begin on the 23rd of the month.

Oil markets could see negative prices this month. Yesterday saw the June contract, which expires on Tuesday, jump higher hitting a two-month high of over $32 per barrel. The easing of lockdown has seen a slight pick-up in demand. However, it has been the output cuts that have had the biggest effect. Back in April OPEC+ members agreed on production cuts, but the likes of Saudi Arabia have cut a lot more.

Inventory data started to show evidence of recovering oil demand last week. Inventory data reported a decline in inventories of 700,000 barrels, the first drop in 16 weeks. The fact that lockdown saw an ease in many countries without a substantial increase of infection cases also helped the prospect that lockdown measures can be eased further meaning demand yet again can pick up.

However, we must be cautious over the current movement in prices. Demand may be improving, but the reaction of prices is very dramatic and knee jerk which may well not be sustained over the medium term.

Share this article:

Disclaimer: This material is a marketing communication and shall not in any case be construed as an investment advice, investment recommendation or presentation of an investment strategy. The marketing communication is prepared without taking into consideration the individual investors personal circumstances, investment experience or current financial situation. Any information contained therein in regardsto past performance or future forecasts does not constitute a reliable indicator of future performance, as circumstances may change over time. Scope Markets shall not accept any responsibility for any losses of investors due to the use and the content of the abovementioned information. Please note that forex trading and trading in other leveraged products involves a significant level of risk and is not suitable for all investors.

Payment Methods

Scope Markets
Scope Markets
Scope Markets
Scope Markets


Scope Markets
Scope Markets
Scope Markets
Scope Markets

Scope Markets offers institutional and retail trading services to businesses and traders worldwide. Our top management team has more than 20 years of experience in the industry, and we are proud of the solid partnerships we built over the years. Whether it's a business or individual, Scope Markets has a wide range of trading solutions that are compliant, flexible, cost-efficient, innovative, and place the client first.

Contact Us

Registered address:
6160, Park Avenue, Buttonwood Bay, Lower Flat Office Space Front, Belize City, Belize


+44 2030 516959

Risk Warning

Please note that forex trading and trading in other leveraged products involves a significant level of risk and is not suitable for all investors. Trading in financial instruments may result in losses as well as profits and your losses can be greater than your initial invested capital. Before undertaking any such transactions, you should ensure that you fully understand the risks involved and seek independent advice if necessary. Please read and ensure you fully understand our Risk Disclosure.

Legal Information

RS Global Ltd is authorized and regulated by the Financial Services Commission of Belize ("FSC") under the Securities Industry Act 2021 with registration number 000274/2.

Restricted Regions

Scope Markets does not offer its services to the residents of certain jurisdictions. Please read carefully our Restricted Countries document.

This website uses cookies to provide you with the very best experience and to know you better. By visiting our website with your browser set to allow cookies, you consent to our use of cookies as described in our Privacy Policy.

© Copyright 2022 Scope Markets. All Rights Reserved.